Anaveon AG

Swiss Biotech Association

Member

Anaveon is a late pre-clinical phase biotech based in Basel, Switzerland. It focuses on the development of next generation IL-2 based therapeutic antibodies for tumor immunotherapy in melanoma, kidney carcinoma and lung cancer.

Products, services, technology

ANV419

Location

Hochbergerstrasse 60C, 4057 Basel, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2017
Number of employees in Switzerland

10-19

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

TissueLabs Sagl

TissueLabs is the platform for creating organs and tissues in the lab. We offer biomaterials, equipment, and services to support tissue engineering and regenerative medicine. Our mission is to fabricate lab-grown tissues and organs, for both research and therapeutic applications.
Via Cantonale 18

Member

Limula SA

Limula SA is developing a platform technology to enable scale out of cell therapy manufacturing, directly at the point of care. We support companies at all stages of the life cycle of their therapies, from R&D to routine production.
La Tour-de-Peilz

Member

Laevoroc Oncology AG

Founded in 2019, Laevoroc is a privately-owned, Swiss oncology group of companies that leverages word-class technologies, our oncology expertise and extensive R&D and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary.
Hünenberg

Member